UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
VIR
Vir Biotechnology, Inc.
There isn't enough reported data to score VIR yet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
VIR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Under pressure | |
| Strong |
VIR's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
VIR PE Valuation
VIR has no meaningful PE right now: it lost money over the past year.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
VIR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect VIR's losses to grow, with revenue declining. However, they disagree widely on these estimates.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
VIR Earnings Per Share
VIR and UNH do not have enough comparable growth data to identify a winner.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over VIR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
VIR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $238.9M | +19583% |
| Q4 2025 | $64.1M | +418% |
| Q3 2025 | $240K | -90% |
| Q2 2025 | $1.2M | -61% |
| Q1 2025 | $3M | -95% |
| Q4 2024 | $12.4M | -26% |
| Q3 2024 | $2.4M | -9.8% |
| Q2 2024 | $3.1M | -19% |
VIR's revenue is recovering but still below its 2022 peak: $239M last quarter, up 19583% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 31% | +9785 points |
| Q4 2025 | -75% | +872 points |
| Q3 2025 | -72268% | -62549 points |
| Q2 2025 | -9754% | -4596 points |
| Q1 2025 | -4602% | -4460 points |
| Q4 2024 | -947% | -119 points |
| Q3 2024 | -9719% | -2643 points |
| Q2 2024 | -5159% | +509 points |
VIR has the edge over UNH on profitability, with a higher operating margin.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over VIR on cash generation, producing positive trailing cash flow while its opponent burns cash.
VIR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $123.3M | +$246.1M |
| Q1 2026 | -$132.8M | -$53M |
| Q4 2025 | -$26.2M | +$63.8M |
| Q3 2025 | -$167.9M | +$5.9M |
| Q2 2025 | -$122.8M | -$44.2M |
| Q1 2025 | -$79.7M | +$31.5M |
| Q4 2024 | -$90M | +$19.4M |
| Q3 2024 | -$173.8M | -$14.3M |
VIR has burned cash in most quarters: −$204M over the past year, against −$466M the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over VIR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
VIR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +21.5M shares |
| 1 year | +22% | +30.4M shares |
| 3 years | +26% | +34.8M shares |
| 5 years | +26% | +35.1M shares |
| Available history | +56% | +60.5M shares |
VIR has 169M diluted shares, up 22% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q2 2022 | — |
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
VIR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -1.0x | Net Cash |
| Q3 2022 | -0.6x | Net Cash |
| Q2 2022 | -1.1x | Net Cash |
| Q1 2022 | -0.5x | Net Cash |
| Q4 2021 | -0.8x | Net Cash |
VIR has more cash than debt.
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
VIR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.2 | Neutral |
| Stochastic | 76.5 | Neutral |
VIR's weekly RSI is 63 (neutral) and its Stochastic is 76 (neutral).
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
VIR PE vs Healthcare Sector
| Metric | VIR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
VIR has no meaningful PE right now: it lost money over the past year.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
VIR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.2 | 8.1% above |
| 20 week MA | $10.4 | 17% above |
| 50 week MA | $9.12 | 33% above |
| 100 week MA | $7.75 | 56% above |
| 200 week MA | $10.7 | 13% above |
VIR has the edge over UNH on trend strength, trading above more of its moving averages.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.
VIR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.4 | $29.5 | +139% |
| 2021 | $29.5 | $41.8 | +41% |
| 2022 | $41.8 | $25.7 | -38% |
| 2023 | $25.7 | $10.1 | -61% |
| 2024 | $10.1 | $7.47 | -26% |
| 2025 | $7.47 | $6.00 | -20% |
| 2026 YTD | $6.00 | $12.1 | +102% |
VIR has the edge over UNH on returns for 2026, with the stronger performance.